This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brodeur, B. R.
Right arrow Articles by Martin, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brodeur, B. R.
Right arrow Articles by Martin, D.

 Previous Article  |  Next Article 

Infection and Immunity, October 2000, p. 5610-5618, Vol. 68, No. 10
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Identification of Group B Streptococcal Sip Protein, Which Elicits Cross-Protective Immunity

Bernard R. Brodeur,* Martine Boyer, Isabelle Charlebois, Josée Hamel, France Couture, Clément R. Rioux,dagger and Denis Martin

Unité de Recherche en Vaccinologie, Centre Hospitalier Universitaire de Québec, et Université Laval, Ste-Foy, Canada G1V 4G2

Received 19 May 2000/Returned for modification 29 June 2000/Accepted 17 July 2000

A protein of group B streptococci (GBS), named Sip for surface immunogenic protein, which is distinct from previously described surface proteins, was identified after immunological screening of a genomic library. Immunoblots using a Sip-specific monoclonal antibody indicated that a protein band with an approximate molecular mass of 53 kDa which did not vary in size was present in every GBS strain tested. Representatives of all nine GBS serotypes were included in the panel of strains. Cloning and sequencing of the sip gene revealed an open reading frame of 1,305 nucleotides coding for a polypeptide of 434 amino acid residues, with a calculated pI of 6.84 and molecular mass of 45.5 kDa. Comparison of the nucleotide sequences from six different strains confirmed with 98% identity that the sip gene is highly conserved among GBS isolates. N-terminal amino acid sequencing also indicated the presence of a 25-amino-acid signal peptide which is cleaved in the mature protein. More importantly, immunization with the recombinant Sip protein efficiently protected CD-1 mice against deadly challenges with six GBS strains of serotypes Ia/c, Ib, II/R, III, V, and VI. The data presented in this study suggest that this highly conserved protein induces cross-protective immunity against GBS infections and emphasize its potential as a universal vaccine candidate.


* Corresponding author. Mailing address: Unité de Recherche en Vaccinologie, Centre Hospitalier Universitaire de Québec, Pavillon CHUL, Édifice T-367, 2705 Boul. Laurier, Ste-Foy, Québec, Canada G1V 4G2. Phone: (418) 656-4141-6266. Fax: (418) 654-2280. E-mail: Bernard.Brodeur{at}crchul.ulaval.ca.

dagger Present address: Intellivax International Inc., Ville St-Laurent, Quebec, Canada H4S 2A1.


Infection and Immunity, October 2000, p. 5610-5618, Vol. 68, No. 10
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Nobbs, A. H., Lamont, R. J., Jenkinson, H. F. (2009). Streptococcus Adherence and Colonization. Microbiol. Mol. Biol. Rev. 73: 407-450 [Abstract] [Full Text]  
  • Santi, I., Grifantini, R., Jiang, S.-M., Brettoni, C., Grandi, G., Wessels, M. R., Soriani, M. (2009). CsrRS Regulates Group B Streptococcus Virulence Gene Expression in Response to Environmental pH: a New Perspective on Vaccine Development. J. Bacteriol. 191: 5387-5397 [Abstract] [Full Text]  
  • Springman, A. C., Lacher, D. W., Wu, G., Milton, N., Whittam, T. S., Davies, H. D., Manning, S. D. (2009). Selection, Recombination, and Virulence Gene Diversity among Group B Streptococcal Genotypes. J. Bacteriol. 191: 5419-5427 [Abstract] [Full Text]  
  • Mavenyengwa, R. T., Maeland, J. A., Moyo, S. R. (2009). Putative Novel Surface-Exposed Streptococcus agalactiae Protein Frequently Expressed by the Group B Streptococcus from Zimbabwe. CVI 16: 1302-1308 [Abstract] [Full Text]  
  • Doro, F., Liberatori, S., Rodriguez-Ortega, M. J., Rinaudo, C. D., Rosini, R., Mora, M., Scarselli, M., Altindis, E., D'Aurizio, R., Stella, M., Margarit, I., Maione, D., Telford, J. L., Norais, N., Grandi, G. (2009). Surfome Analysis as a Fast Track to Vaccine Discovery: IDENTIFICATION OF A NOVEL PROTECTIVE ANTIGEN FOR GROUP B STREPTOCOCCUS HYPERVIRULENT STRAIN COH1. Mol. Cell. Proteomics 8: 1728-1737 [Abstract] [Full Text]  
  • Bray, B. A., Sutcliffe, I. C., Harrington, D. J. (2009). Impact of lgt mutation on lipoprotein biosynthesis and in vitro phenotypes of Streptococcus agalactiae. Microbiology 155: 1451-1458 [Abstract] [Full Text]  
  • Brochet, M., Couve, E., Bercion, R., Sire, J.-M., Glaser, P. (2009). Population Structure of Human Isolates of Streptococcus agalactiae from Dakar and Bangui. J. Clin. Microbiol. 47: 800-803 [Abstract] [Full Text]  
  • Yang, H.-H., Mascuch, S. J., Madoff, L. C., Paoletti, L. C. (2008). Recombinant Group B Streptococcus Alpha-Like Protein 3 Is an Effective Immunogen and Carrier Protein. CVI 15: 1035-1041 [Abstract] [Full Text]  
  • Yang, H.-H., Madoff, L. C., Guttormsen, H.-K., Liu, Y.-D., Paoletti, L. C. (2007). Recombinant Group B Streptococcus Beta C Protein and a Variant with the Deletion of Its Immunoglobulin A-Binding Site Are Protective Mouse Maternal Vaccines and Effective Carriers in Conjugate Vaccines. Infect. Immun. 75: 3455-3461 [Abstract] [Full Text]  
  • Henneke, P., Berner, R. (2006). Interaction of neonatal phagocytes with group B streptococcus: recognition and response.. Infect. Immun. 74: 3085-3095 [Full Text]  
  • Schuijffel, D. F., van Empel, P. C. M., Pennings, A. M. M. A., van Putten, J. P. M., Nuijten, P. J. M. (2005). Successful Selection of Cross-Protective Vaccine Candidates for Ornithobacterium rhinotracheale Infection. Infect. Immun. 73: 6812-6821 [Abstract] [Full Text]  
  • Maione, D., Margarit, I., Rinaudo, C. D., Masignani, V., Mora, M., Scarselli, M., Tettelin, H., Brettoni, C., Iacobini, E. T., Rosini, R., D'Agostino, N., Miorin, L., Buccato, S., Mariani, M., Galli, G., Nogarotto, R., Dei, V. N., Vegni, F., Fraser, C., Mancuso, G., Teti, G., Madoff, L. C., Paoletti, L. C., Rappuoli, R., Kasper, D. L., Telford, J. L., Grandi, G. (2005). Identification of a Universal Group B Streptococcus Vaccine by Multiple Genome Screen. Science 309: 148-150 [Abstract] [Full Text]  
  • Sekizaki, T., Takamatsu, D., Osaki, M., Shimoji, Y. (2005). Different Foreign Genes Incidentally Integrated into the Same Locus of the Streptococcus suis Genome. J. Bacteriol. 187: 872-883 [Abstract] [Full Text]  
  • Lindahl, G., Stalhammar-Carlemalm, M., Areschoug, T. (2005). Surface Proteins of Streptococcus agalactiae and Related Proteins in Other Bacterial Pathogens. Clin. Microbiol. Rev. 18: 102-127 [Abstract] [Full Text]  
  • Hamel, J., Charland, N., Pineau, I., Ouellet, C., Rioux, S., Martin, D., Brodeur, B. R. (2004). Prevention of Pneumococcal Disease in Mice Immunized with Conserved Surface-Accessible Proteins. Infect. Immun. 72: 2659-2670 [Abstract] [Full Text]  
  • Larsson, C., Holmgren, J., Lindahl, G., Bergquist, C. (2004). Intranasal Immunization of Mice with Group B Streptococcal Protein Rib and Cholera Toxin B Subunit Confers Protection against Lethal Infection. Infect. Immun. 72: 1184-1187 [Abstract] [Full Text]  
  • Tettelin, H., Masignani, V., Cieslewicz, M. J., Eisen, J. A., Peterson, S., Wessels, M. R., Paulsen, I. T., Nelson, K. E., Margarit, I., Read, T. D., Madoff, L. C., Wolf, A. M., Beanan, M. J., Brinkac, L. M., Daugherty, S. C., DeBoy, R. T., Durkin, A. S., Kolonay, J. F., Madupu, R., Lewis, M. R., Radune, D., Fedorova, N. B., Scanlan, D., Khouri, H., Mulligan, S., Carty, H. A., Cline, R. T., Van Aken, S. E., Gill, J., Scarselli, M., Mora, M., Iacobini, E. T., Brettoni, C., Galli, G., Mariani, M., Vegni, F., Maione, D., Rinaudo, D., Rappuoli, R., Telford, J. L., Kasper, D. L., Grandi, G., Fraser, C. M. (2002). Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae. Proc. Natl. Acad. Sci. USA 99: 12391-12396 [Abstract] [Full Text]  
  • Martin, D., Rioux, S., Gagnon, E., Boyer, M., Hamel, J., Charland, N., Brodeur, B. R. (2002). Protection from Group B Streptococcal Infection in Neonatal Mice by Maternal Immunization with Recombinant Sip Protein. Infect. Immun. 70: 4897-4901 [Abstract] [Full Text]  
  • Areschoug, T., Stalhammar-Carlemalm, M., Karlsson, I., Lindahl, G. (2002). Streptococcal beta Protein Has Separate Binding Sites for Human Factor H and IgA-Fc. J. Biol. Chem. 277: 12642-12648 [Abstract] [Full Text]  
  • Hughes, M. J. G., Moore, J. C., Lane, J. D., Wilson, R., Pribul, P. K., Younes, Z. N., Dobson, R. J., Everest, P., Reason, A. J., Redfern, J. M., Greer, F. M., Paxton, T., Panico, M., Morris, H. R., Feldman, R. G., Santangelo, J. D. (2002). Identification of Major Outer Surface Proteins of Streptococcus agalactiae. Infect. Immun. 70: 1254-1259 [Abstract] [Full Text]  
  • Rioux, S., Martin, D., Ackermann, H.-W., Dumont, J., Hamel, J., Brodeur, B. R. (2001). Localization of Surface Immunogenic Protein on Group B Streptococcus. Infect. Immun. 69: 5162-5165 [Abstract] [Full Text]